Naltrexone Augmentation of Nicotine Patch Therapy - 1

NCT00218153 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

200

Enrollment

NIH

Sponsor class

Conditions

Tobacco Use Disorder

Interventions

DRUG: Naltrexone

Sponsor

National Institute on Drug Abuse (NIDA)